
TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies by overcoming current critical manufacturing issues. TreeFrog Therapeutics has developed C-Stem® : a proprietary technology platform that provides an end to end 3D scalable solution that will dramatically reduce treatment costs. Through strategic partnership and co-developments, TreeFrog Therapeutics will help cell therapy players to secure cell production and quality, fasten clinical development and facilitate market access
Investment Date
2019
Country
France
Sector
Biotech
Investor(s)

Guilhem de Vregille
Partner Paris
1 job
Senior Research Associate
Tissue Culture
Stem Cells
RNA
Cell Differentiation
Pharmaceutical Industry
3D
ELISA
Characterization
RT-PCR
Biotechnology
IPS
State & Local
Attention to Detail
Liver
Research
Method Development
Cell Therapy
RNA Sequencing
Diabetes
Western Blot
Biology
Cambridge, Massachusetts, United States177 Employees
Posted 2 weeks ago